The effect of feeding live Lactobacillus reuteri cells containing active bile salt hydrolase (BSH) on plasma cholesterol levels was studied in pigs. During an experiment lasting 13 weeks, twenty pigs were fed on a high-fat, high-cholesterol, low-fibre diet for the first 10 weeks, and a regular pig diet for the last 3 weeks. One group of animals received, twice daily, 11.25 (SD 0.16) loglo colony forming units of the potential probiotic bacteria for 4 weeks (from week 3 until week 7). From week 8 onwards, the treated group was again fed on the same diet as the control group without additions. The total faecal Lactobacillus counts were only significantly higher in the treated pigs during the fist 2 weeks of L. reuteri feeding. Based on limited data, it was suggested that the administered LactobacilZus species had caused a temporary shift within the indigenous Lactobacillus population rather than permanently colonizing the intestinal tract. The probiotic feeding brought about significant lowering (P 5 0.05) of total and LDL-cholesterol concentrations in the treated pigs compared with the control pigs, while no change in HDLcholesterol concentration was observed. The data for faecal output of neutral sterols and bile salts were highly variable between the animals of each group, yet they indicated an increased output in the treated pigs. Although the blood cholesterol levels went up in both groups during the 3 weeks following the Lactobacillus administration period, significantly lower serum total and LDL-cholesterol levels were observed in the treated pigs. During the final 3 weeks of normalization to the regular diet, cholesterol concentrations significantly decreased in both animal groups and the differences in total and LDL-cholesterol concentrations between the groups largely disappeared.
Blood cholesterol concentration is largely determined by dietary fat and cholesterol intake. Fat-and cholesterol-rich Western diets are also often deficient in fibre, which is reported to promote more rapid bowel transit and increased faecal excretion of fat, cholesterol and bile salt derivatives (Costa et al. 1994) . Results from several epidemiological and clinical studies indicate a positive correlation between elevated total serum cholesterol levels, mainly reflecting the LDL-cholesterol, and the development of atherosclerosis and related cardiovascular diseases.
With the emergence of a more health conscious society, the role of probiotic food products in human health has gained much attention from both consumers and producers. Lactic acid bacteria have often been suggested to exert beneficial effects on human health. As reviewed by De Smet et al. (1994) , lactic acid bacteria with the active biile salt hydrolase (BSH), or cultured products containing them, are suggested to bring about a lowering of serum cholesterol levels through an interaction with the host's bile salt metabolism. The proposed mechanism of cholesterol lowering is comparable with that of a cholestyramine treatment which, like other bile salt sequestrants such as colestipol, binds bile salts and prevents them from being reabsorbed (Grundy, 1972; Suckling et al. 1991) . Thus, a decreased amount of bile salts would return to the liver, resulting in a loss of feedback inhibition of bile salt synthesis and an increased conversion of cholesterol to bile salts. The ingestion of lactic acid bacteria containing active BSH results in higher proportions of deconjugated free bile salts, which are less water-soluble and are more easily excreted via the faeces (De Smet et al. 1994) . This drain on the bile salt pool might be regarded as a 'biological' alternative to common medical or surgical interventions to treat hypercholesterolaemia (De Smet et al. 1994) .
Based on these dietary elements, a pig experiment was designed to assess the impact of ingestion of BSH-active lactobacilli on serum cholesterol levels. It was suggested that this might only be properly studied in a population that deviates from the 'normal, healthy' status because of strong homeostatic regulation of cholesterol metabolism in normal conditions which is also seen in human subjects (De Smet et al. 1994) . Therefore, hypercholesterolaemia was induced in the animals by feeding them on a diet rich in cholesterol and saturated fat and low in fibre content. The contents of fat (30 % total energy intake) and cholesterol (2-4 g/kg) in the 'Western type' diet were in line with those applied in other pig experiments investigating features related to blood and/or faecal sterol levels (Mott et al. 1973; Kim et al. 1980; Juste et al. 1983; Danielson et a1. 1989; Costa et al. 1994) .
The main objective of the present study was to validate the hypothesis that enhancing BSH activity, through feeding the highly BSH-active L. reuteri strain, might lower serum cholesterol levels in pigs (De Smet et al. 1994) . The study also aimed to evaluate the effect of probiotic feeding on faecal variables such as pH, DM content and bacteriology, and on the overall growth performance of the pigs.
Materials and methods

Animals
Twenty Seghers hybrid (sow) x PiCtrain (boar) pigs (ten females and ten castrated males) of about 30 kg live weight, aged 10 weeks, were divided into two experimental groups i.e. the control pigs and the pigs to be treated with the probiotic. The pigs were allocated to one of the groups in such a way that both groups showed equal distributions of the sexes, and equal initial weights and cholesterol levels. The animals were housed in separate cages in a temperature-controlled room (22 (SD 1)") at the Rijksstation voor Veevoeding in Melle-Gontrode (Belgium). The pigs were inspected daily for any evidence of diarrhoea, constipation or other illnesses or anomalies, and were weighed at the beginning and end of each experimental period. An extra weighing was done in the middle of the probiotic feeding period.
Experimental outline and diets
The experiment lasted 13 weeks (Table 1) . During the first 5 weeks, all pigs received a 'Western type' high-fat, lowfibre diet, which contained 2 g cholesterol/kg (Tables 2 and  3 ). During the following 5 weeks, the animals were fed on the same hypercholesterolaemic diet but the cholesterol content was doubled (4g/kg). This was done because the serum cholesterol levels did not increase sufficiently during the first 5 weeks. During the period from week 4 to week 7, the L. reuteri-treated group received the probiotic strain at both morning and evening feeds. During the last 3 weeks, all animals received a regular diet obtained from Valora (Ingelmunster, Belgium) without cholesterol addition (Table 3) .
Probiotic strain and preparation of the probiotic feed supplement
The Lactobacillus strain used was isolated from fresh pig faecal material on Rogosa agar plates (Oxoid; Unipath, Gent, Belgium -70" in appropriate portions. Before feeding, the probiotic supplements were thawed at room temperature and added to the water to be mixed with the feed. Viable cell counts and BSH activity of the stored cultures were checked regularly. A dose of 11.25 (SD 0.16) loglo L. reuteri cells was added to each morning and afternoon feed of the treated pigs during period 2 (Table 1) . 
Acclimatization of the pigs, feeding and ration-setting
At the start of the experiment, the animals were acclimatized to the hypercholesterolaemic diet for 3 weeks, during which they were fed twice daily (feed-water, 1.0: 1.5) at 08.00 and 16.00 hours. The daily feed intake of the pigs was carefully controlled because, first, blood cholesterol levels are very sensitive to the amount of feed consumed, and second, because the strain was mixed with the feed. Therefore, the amount of feed, given in two equal meals, was restricted to assure complete intake. Feed consumption was measured daily and the ration was adjusted weekly by calculating the feed efficiency ratio (FER), i.e. feed uptake : growth (g/d). On incomplete feed intake, rations were adjusted downwards to minimize interindividual differences in feed intake. The pigs had free access to drinking water.
Blood sampling and cholesterol analysis
Blood samples (about 10 ml) were taken by venepuncture at the beginning and end of each experimental period, including an extra sampling after 2 weeks of L. reuteri dosage. The samples were taken after an overnight fast before the 08.00 hours feeding. Serum was prepared and immediately analysed for total cholesterol (Allain et al. 1974) , HDL-cholesterol (Wamick et al. 1982 ) and triacylglycerols (Fossati & Prencipe, 1982) . LDL-choles-terol was calculated from the difference between total and HDL-cholesterol and triacylglycerols (Friedewald et al. 1972) .
Faecal sampling and analysis
Fresh faecal material (50-100 g wet weight) was collected weekly or fortnightly for microbiological analysis, pH and DM determination. The faeces were transported in a coo1 box and processed within 1 h after sampling. The viable concentrations (loglo CFU/g faeces) of total lactobacilli, enterobacteriaceae and faecal streptococci were determined on Rogosa agar (Oxoid), Violet Red Bile Glucose agar (Oxoid) and Slanetz and Bartley agar (Taylor & Burman, 1964) respectively. At weeks 10 and 12, a qualitative screening for tauroconjugate hydrolytic lactobacilli was performed by the plate assay of Dashkevicz & Feighmer (1989) . The pH of the faecal samples was determined after 1 h homogenization of 5 g faeces in 50ml distilled water. DM was determined after 24h drying at 110". Portions of the samples were frozen at -20" for analysis of total bile salt and neutral sterol content.
Total faecal bile salt concentrations were determined after methanol extraction by the colorimetric assay of Mashige et al. (1981) using the bile salts fully enzyrnic colour Merckotest@ kit (Merck, Darmstadt, Germany). The principle of the test is based on the conversion of :?mhydroxy bile salts to the corresponding 3-keto derivatives in the presence of NAD+ and with the aid of : 3~hydroxysteroid dehydrogenase (EC 1.1.1 S3). The NAD formed reacts with nitrotetrazolium blue under the catalytic influence of diaphorase to give a blue formazan derivative, which can be quantified by measuring the absorbance. Faecal matter (1 g) was dissolved in 40 ml methanol. After 4min sonication and 1 h shaking, the mixtures were centrifuged (10 OOOg, 10 min) and 100 pl of the supernatant fraction was used to determine the bile salt content. The faecal bile salt and neutral sterol profiles were analysed by GC according to the method of Lapr6 et al. (1993) . Briefly, dried samples were pulverized and pooled. Pooled samples were made of randomly chosen individual samples of each group. In addition, a number of samples were analysed individually to establish interindividual variances witlhin one group. The pulverized faecal samples were hydrolysed in methanol and NaOH at 80". Neutral sterols were extracted with hexane, whereas bile salts were extracted with ether after acidification of the samples with HCI. Subsequently, the extracts were methylated and silylated, evaporated and resuspended in hexane before GC analysis.
Statistical analysis
Results were analysed by one-way ANOVA. When statistically significant differences were found, mean values of treatments were compared by Student's t test.
Results
Animals
Although some pigs showed slightly watery faeces during the first 2 d of acclimatization to the high-fat-highcholesterol diet, and some pigs refused part of their diets during the first days after the shift from the high-fat-highcholesterol porridge feeding to the regular pig diet, the animals generally adapted well to the experimental conditions. One control pig showed an aberrant high FER during the normalization period. This was of temporary concern and not related to the probiotic feeding or the cholesterol rich diet. The high FER was probably due to the sudden switch to the normal diet. The pigs treated with the L. reuteri supplement did not develop illnesses or adverse effects compared with the control animals, and no significant differences in body weight were observed between the two animal groups throughout the experiment (Tables 4 and 5) . During week 10, one of the control pigs died for an unknown reason the day after the weighing. Table 1 t n 9 for CP.
Blood cholesterol and triacylglycerols
feeding, the total and LDL-cholesterol levels in the treated pigs were reduced by 11 and 26 % respectively, compared with the control animals (P10.05), while after 4 weeks these reductions were 15 and 24 % (P 5 0.05) respectively ( Fig. 1 (a,b) ). In the 3 weeks of post-treatment follow-up, the treated pigs showed 18 % lower total cholesterol concentrations (P 5 0.05) and 34 % lower LDL-cholesterol concentrations ( P 5 0.01) ( Fig. l(a,b) ). This could have been due either to a temporary shift towards a more BSHactive Lactobacillus population, or to the fact that serum cholesterol levels change only slowly in response to a highfat-high-cholesterol diet. As it had taken 10 weeks for the total cholesterol levels in the control pigs to rise from 2.46 to about 3.44mmol/l, it is rather doubtful that the total cholesterol level of the treated pigs could increase to that of the control pigs in a 3-week period. Compared with the control pigs, the total and LDLcholesterol levels in the treated pigs were lower during the 4 weeks of probiotic feeding. During the subsequent posttreatment follow-up period, the total and LDL-cholesterol concentrations in the treated pigs increased, but the levels were still significantly lower than the values measured in the control pigs. HDL-cholesterol levels were not significantly altered on L. reuteri feeding ( Fig. l(c) ).
In the control pigs, a gradual increase of the total and LDL-cholesterol concentrations was observed during the 10 weeks of high-fat-high-cholesterol feeding ( Fig. 1 (a,b) ), while no consistent changes were found for the HDLcholesterol levels (Fig. l(c) ). The increases in total and LDL-cholesterol levels in the control pigs at week 10 compared with week 3 were about 25% and 60% respectively ( Fig. l(a,b) ). When comparing the total cholesterol concentration in the treated pigs during the treatment period, with the total cholesterol concentration at week 3, an average lowering of approximately 7 % (P > 0.1) was observed. At week 10 the total cholesterol concentration in the L. reuteri-treated pigs was about 5 % ( P > 0.1) higher than at the start of the probiotic feeding at week 3, mainly due to an increase in the HDL-cholesterol concentration. When comparing the LDL-cholesterol concentration in the L. reuteri-treated pigs during the treatment Table 5 . Average growth, feed uptake and feed efficiency ratio (FER) of control pigs (CP; n 10) and pigs treated with live Lacfobaci//us reuferi cells twice daily from week 3 to week 7 (TP; n 10)'
(Mean values and standard deviations)
Experimental period ...
Week 0-3
Week 3-5
Week 5-7
Week 7-10
Week 10 Values are means for ten pigs with standard deviations indicated by vertical bars, except for week 13 control values where n 9. (t),
Probiotic feeding period. Mean values were significantly different for the two groups: "Pi 0.05, **Pi 0.01. period, with the LDL-cholesterol concentration at week. 3, also an average lowering of approximately 7 % ( P > 0.1) was observed. The LDL-cholesterol levels measured in the treated pigs at week 10 were significantly (P10.01) different from levels measured in the same pigs at week; 5.
The observed lowering at week 5 can be explained by the addition of L. reuteri together with the cholesterol-rich (2 g/kg) diet. At week 5 the cholesterol amount was doubled (4 g/kg) and the LDL-cholesterol levels slightly increased in the treated pigs, while they increased more in the control pigs. Therefore, it is believed that the effects brought ablout by the supplemented strain could not fully counterbalance the effect of doubling the cholesterol concentration in the diet and hence led to an increase of the LDL-cholesterol concentration. The observed increase of total and LDLcholesterol levels of the treated pigs between week 7 amd week 10 was however clearly less than the increase of ithe levels in the control pigs. During the last 3 weeks a commercial pig diet without cholesterol supplementation was fed, causing the cholesterol levels in both experimental groups to decrease even below the levels at the onset of the experiment (Fig. 1) . At that time, LDL-cholesterol levels were no longer significantly different between the two groups ( Fig. l(b) ), while the total serum cholesterol concentrationi in the treated pigs was still significantly lower ( P 5 0-05; Fig.   l(a) ), mainly due to the lower HDL concentrations ( P 5 0.10) in these animals ( Fig. l(c) ).
The triacylglycerol concentrations did not differ significantly between the control and treated pigs throughout the experiment. The initial triacylglycerol levels for the control and treated pigs were respectively 0.56 (~~0 . 0 5 ) and 0.53 (SD 0.06) mmol/l. At the start and end of the probiotic feeding these levels were for the control pigs 0.58 (SD 0.06) and 0.44 (SD 0.07) mmol/l, and for the treated pigs 0.48 (SD 0.04) and 0.46 (SD 0.04) mmol/l. After 3 weeks post-treatment followup and the final 3 weeks of normalization to the regular pig diet, the triacylglycerol concentrations in the control pigs were 0.39 (SD 0.03) and 0.44 (SD 0.05) mmol/l respectively, whereas for the treated pigs they were 0.44 (SD 0.03) and 0.43 (SD 0.05) mmol/l respectively.
Faecal excretion of bile salts and neutral sterols
The data on total faecal bile salt excretion determined colorimetrically, reveal that the total bile salt output increased in both animal groups during the course of the 'Western type' diet feeding (Fig. 2) . A 25 % higher excretion ( P 5 0.05) was observed in the treated group compared with the control group after 1 week of L. reuteri ingestion. This higher output lasted until the end of the Lactobacillus treatment, and it decreased again to the level of the control animals after the treatment was stopped. The faecal bile salt excretions in the control pigs however also increased due to the high-fat and high-cholesterol feeding. Compared with the initial value (week 0, Fig. 2 ), the faecal output was increased by 13 % (P 5 0.10) at week 6, 26 % at week 8 ( P 5 0.10), and 25 % at week 10 ( P 5 0.01). A detailed faecal bile salt profile was obtained by GC analysis, and the data on the three major compounds, i.e. lithocholic acid (LCA), hyodeoxycholic acid (HDCA) and hyocholic acid (HCA) are presented in Table 6 . The concentrations of cholic, deoxycholic, chenodeoxycholic and a-muricholic acid are not given separately in Table 6 , because they were lower than 0.5pmol/g dry faeces or even below the detection limit (0.1 pmol/g dry faeces). The total bile salt concentrations were approximately a factor of ten higher compared with those given in Fig. 2 , which may be attributed to methodological aspects such as different extraction or detection efficiencies of the respective assays. The evolution in time of the total bile salt excretion was found to be variable, and large interindividual variances were observed between the animals of one group (variances of the values in square brackets, Table 6 ). When evaluating the data obtained from the analysis of four individual samples (values in square brackets, Table 6 ), there was a trend towards higher bile salt excretions in the faeces of treated pigs. However, these results calculated from four individually analysed samples differed greatly from those of the five-sample pooling of week 6 for the same experimental group (Table 6 ). Hence, no unequivocal conclusions should be drawn from these pooled data.
Finally, it was found that the ratio HCA : (HDCA + LCA),
i.e. primary : secondary bile salts, was markedly decreased in both groups on feeding the 'Western type' diet, i.e. from 0.35 at the start of the experiment to less than 0-10 after 8 weeks high-fat-high-cholesterol feeding ( Table 6) . Although no major differences were observed between the two animal groups, this ratio was slightly higher (about 1.2-1 a 6 times) in the treated pigs during the probiotic feeding. Table 6 also gives the faecal concentrations of cholesterol and total neutral sterols. The total neutral sterol output increased on high-fat-high-cholesterol feeding, whereas it decreased markedly at week 12, i.e. 2 weeks after the 'Western type' diet feeding was stopped. The individual faeces samples of the treated pigs showed a significantly lower ( P 5 0.01) cholesterol excretion in week 6. The cholesterol, coprostanol and total neutral sterol outputs in the control pigs at week 12 were significantly lower ( P 5 0.05) compared with the treated pigs. It could also be calculated that during the high-fat-high-cholesterol feeding the cholesterol : coprostanol ratio changed in a similar way in both groups. At the start of the experiment it was about 0.35 in both groups but by week 6, the ratios calculated from the data of the four individual analyses were, for the control and treated pigs, lowered to 0.27 and 0.17 respectively, which were significantly different (P 5 0.05). At week 12, the cholesterol : coprostanol values had again increased to 0.57 in the control pigs and 0.40 in the treated pigs.
p H and DM of the faeces
No significant differences in pH and DM content were observed on probiotic feeding compared with the control pigs (Table 7) . Fig. 3 shows the faecal Lactobacillus counts in the control and treated pigs. The average Lactobacillus count in the control animals was significantly higher compared with the treated pigs ( P I 0.05) in week 2, while from week 3 to week 5 the Lactobacillus counts of the treated pigs were significantly higher than those of the control pigs. However, no significant differences were observed from week 6 until the end of the experiment. The numbers of faecal streptococci and enterobacteriaceae were not significantly different between the groups, except for the concentrations of faecal streptococci in the treated pigs in week 6, and of the enterobacteriaceae in week 8, which were significantly lower ( P 5 0.05) compared with the respective counts of the control pigs (results not shown), Total and LDL-cholesterol levels were still significantly lower 3 weeks after the probiotic feeding was stopped despite the fact that the total numbers of lactobacilli had returned to their initial levels. This may, in part, have betm a consequence of the probiotic feeding, whereby a temporary shift in the lactobacilli population occurred, through which the administered strain partly replaced the native lactobacilli and exerted a prolonged effect on the serum cholesterol level. To verify this, the numbers d BSH-active lactobacilli present in the faeces at the last two samplings, i.e. at weeks 10 and 12, were enumerated by means of the plate assay of Dashkevicz & Feighner (1 989). Table 8 illustrates that, in week 10, there was a trend towards a higher amount of BSH-active lactobacilli in the treated pigs (32.45%) compared with the control pigs (21-96 %). The relative amount of BSH-active lactobacilli decreased in the treated pigs to 20430% in week 12 (P 5 O.lO), whereas it remained approximately the same for the control pigs over that 2-week period. However, the data are too limited to fully substantiate the thesis that there WiaS a temporary shift towards a more BSH-active lactobacillus population in the treated pigs. Further studies, in which the variation of faecal BSH-active lactobacilli is followed throughout the whole experiment, are required.
Bacteriological examination of the faeces
Discussion
The main goal of the present study was to evaluate the effect of feeding the BSH-active L. reuteri strain on the blood cholesterol levels of pigs in order to validate the hypothesis that enhanced intestinal BSH activity miglht lower blood cholesterol levels ( De Smet et af. 1994) . Evidence for this mechanism was sought in a combined study of blood cholesterol levels and faecal bile salt and neutral sterol content. Ratcliffe & Luginbiihl (1971) found the pig to be one of the most suitable models to study atherosclerosis, because the distribution of coronary arteries and atherosclerotic tendencies in pigs resemble those of man. Furthermore, apart from their similar digestive systems (Miller & Ullrey, 1987) , pigs and human subjects were also reported to have a similar lipoprotein metabolism and extensive apolipoprotein homology (Chapman, 1986; Black & Davidson, 1989; Black et al. 1990) ..
In the present study, HDL-cholesterol concentrations were not significantly altered after 4 weeks of Lactobacillus Table 8 . Viable counts of total and bile salt hydrolase-active (BSH+) lactobacilli (log,, colony-forming units/g wet faeces) in the faeces of control pigs (CP; n 10) and pigs treated with live Lactobacillus reuteri cells twice daily from week 3 to week 7 (TP; n 10)'
(Mean values and standard deviations)
BSH' lactobacilli Total lactobacilli
BSHt lactobacilli ( tn 9 for CP group feeding (Fig. l(c) ), whereas the total and LDL-cholesterol levels were significantly lower by 15 and 24 % respectively compared with the control animals. When comparing the evolution in time of the total and LDL-cholesterol fractions, a clear cholesterol controlling effect of the L. reuteri cells is demonstrated. As expected, cholesterol concentrations markedly decreased in both animal groups and the differences between the groups largely disappeared during the final 3 weeks of normalization to the regular pig diet (Fig. 1) . Triacylglycerol levels were not found to be significantly different between the control and treated pigs throughout the experiment. In this context, the net positive effect on plasma cholesterol obtained in the present pig experiment should be compared with the cholesterol reductions on therapeutic or surgical interruption of the enterohepatic cycle (EHC), which have been reported to be in the range of 1 5 3 0 % (Grundy, 1972; Grundy et al. 1972) . It was shown that the total faecal bile salt excretion, as determined enzymically, increased in both animal groups throughout the high-fat-high-cholesterol feeding period, whereas it decreased again on feeding the regular pig diet (Fig. 2) . This finding is in agreement with the reported higher faecal excretion due to diets rich in fat and cholesterol (Aries et al. 1969; Armstrong & Doll, 1975; van Faassen et al. 1987; Korpela et al. 1988) . A significantly higher excretion was determined in the treated pigs during the probiotic addition (Fig. 2) . No such consistent data were obtained by GC analysis of pooled samples (Table 6 ). Besides the observed increases and decreases in faecal neutral sterol output in both groups in response to the high and low dietary fat and cholesterol intakes respectively (Table 6) , the interindividual differences were such that the analysis of pooled samples of five randomly chosen samples did not yield interpretable data.
Despite the discrepancies in the data on faecal bile salts of Fig. 2 and Table 6 , they partly indicate changes in bile salt metabolism due to ingestion of BSH-active lactobacilli. In this regard, several reports have described the role of the indigenous bacteria in the overall bile salt metabolism (Gustafsson et al. 1977; Madsen et al. 1978; Chikai et al. 1987) . These studies, performed with germ-free rats or rats in which the normal microbiota was selectively eliminated by antibiotics, demonstrated lower faecal bile salt excretions and no free bile salts in germ-free animals, due to the absence of the normal BSH-active microbiota. Mott et al. (1973) reported that when germ-free pigs developed an intestinal microbiota, microbial conversion of cholesterol to coprostanol and of primary to secondary bile salts was responsible for increased neutral sterol excretions and bile salt turnover rates and a concomitant decrease in serum cholesterol levels.
Although the impact of changes in the EHC due to bile salt and/or cholesterol metabolism on the development of atherosclerosis has been recognized, there is a medical concern about possible side-effects. According to some authors (Hylemon & Glass, 1983; Kandell & Bernstein, 1991) enhanced BSH activity in the gut is not desirable because dehydroxylation of primary bile salts to cocarcinogenic and co-mutagenic secondary free bile salts, which could induce colorectal cancer, can take place more easily after the initial deconjugation (Cohen et al. 1980; Owen et al. 1986; van Faassen et al. 1987; Nagengast et al. 1995) . In particular the increase in faecal secondary bile salts on ingestion of BSH-active lactobacilli should, according to Marteau et al. (1995) , be regarded as a potential long-term colon cancer promoting effect. It was demonstrated that the ratio primary : secondary bile salts was reduced in both experimental groups on feeding the high-fat-high-cholesterol diet. Although the ratio primary: secondary bile salts was found to be slightly higher in the treated pigs on probiotic feeding, these data were subject to large variability (Table 6) . Similarly, as for bile salts, increased faecal neutral sterol excretion has been associated with an increased risk of colorectal cancer (van Faassen et al. 1987; Korpela et al. 1988 ). In addition, intestinal bacterial metabolism of neutral sterols has also been suggested as a risk factor, although inconsistent and conflicting results have been reported on this aspect (van Faassen et al. 1987; Korpela et al. 1988 ). However, our data did not allow this aspect to be assessed and this should be further investigated.
The administration of 11.25 (SD 0.16) loglo L. reuteri cells twice daily resulted in significantly higher faecal Lactobacillus counts during the first 2 weeks of Lactobacillus feeding only (Fig. 3 ) and no consistent changes were observed in the numbers of enterobacteriaceae and faecal streptococci (results not shown). Because the proportion of BSH-active lactobacilli among the total faecal lactobacilli decreased in the treated pigs after the L. reuteri addition was stopped (Table 8) , it was presumed that the L. reuteri cells were gradually washed out and that they did not succeed in permanently colonizing the intestinal tract. This suggested temporary shift within the intestinal Luctobacil-Zus population corroborates the finding of Wolf et al. (1995) that human subjects, who had consumed 11 loglo L. reuteri cells daily for 3 weeks, showed no increase in total faecal lactobacilli, although they did show an increase in the relative proportion of L. reuteri.
The faecal pH and DM content (Table 7 ) did not change significantly on feeding the L. reuteri strain. These variables were within the normal values reported in the literature, i.e. about 25 % for the DM content and between 6.5 and 7.0 for the faecal pH (Kidder & Manners, 1978) . No diarrhoea was observed in the treated pigs, although fat malabsorption and diarrhoea have been suggested as potential dangerous sideeffects of the ingestion of BSH-active lactic acid bacteria (Marteau & Rambaud, 1993; Marteau et al. 1995) . During week 10, one of the control pigs died for an unknown reason, but no illnesses or adverse effects were otherwise observed in any of the pigs. The treated animals in the present experiment showed no impairment of growth performance (Tables 4 and 5 ) and the dose of 11.25 (SD 0.16) loglo L. reuteri twice daily was shown to be tolerated well. This is in agreement with the report of Wolf et al. (1995) in which no significant safety or tolerance problems were observed in male subjects after several weeks consumption of a similar dose of an L. reuteri strain.
Agerbaek et al.
( 1 995) demonstrated in human subjects a 10 % reduction in LDL-cholesterol due to the consumption of a fermented milk containing an Enterococcus faecium strain and two Streptococcus thermophilus strains. Although the E. faecium strain was suggested to be responsible for the cholesterol lowering, no mechanism of action was proposed. Apart from this human study, most studies published have used small laboratory animals. Fukushima & Nakano (1995) demonstrated a mixture of several Bacillus, Lactobacillus, Streptococcus, Saccharomyces and Candida strains to lower significantly total and LDL-cholesterol and to increase HDL-cholesterol concentrations in rats kept on a high-fat and high-cholesterol (10 g/kg) diet. This coincided with increased faecal neutral and acidic sterol concentrations. No specific mechanism was claimed, but it was suggested that the probiotic mixture might have been effective through symbiotic relationships in the intestine, by improving the intestinal microbial balance and by promoting the binding of bile salts and the inhibition of micelle formation in the intestine (Fukushima & Nakano, 1995 ). Tannock et al. (1994 , who inoculated reconstituted lactobacilli-free (RLF) mice with three BSHactive Lactobacillus strains, showed an 86% increase in BSH activity, and a concomitant increase in deconjugated bile salts in the intestinal tract of these RLFL mice (i.e. RLF mice inoculated with lactobacilli) compared with the FUF mice. In a mouse experiment by Tannock & McConnell (1994) , the same mode of action as we investigated in the present pig experiment was proposed, namely cholesterol lowering through (enhanced) BSH activity of lactobacilli. After inoculating RLF mice with BSH-active Lactobacillus strains, the serum cholesterol levels of the RLFL mice were reduced by 4-5 % compared with RLF mice. No data were reported on faecal stelrol output (Tannock & McConnell, 1994) . As these investigators found the cholesterol lowering to be insignificant, they concluded that lactobacilli originating from conventional mice did not influence the cholesterol balance. However, as it was not reported how many viable lactobacilli were effectively inoculated, it could be expected that a more pronounced effect might have been achieved at sufficient Lactobacillus doses. Probiotic effects on cholesterol are likely to be dose-dependent, in a similar way as medical therapies in this field. In addition, Suckling et al. (1991) demonstrated that the 'minimal effective dose' and 'doseresponse relationship' of cholestyramine treatment differed in human subjects, dogs and hamsters in the extent to which the removal of bile salts lowered cholesterol. The dosage of 11.25 (SD 0.16) loglo L. reuteri cells in our pig experiment yielded total and LDL-cholesterol reductions in the order of 25-35% and 10-20% respectively compared with the control animals. Therefore, the reported positive relationship in pigs between increased faecal neutral sterols aind bile salts and serum cholesterol lowering (Mott et al. 1973; Dupont et al. 1974; Kim et al. 1980; Scholz et al. 1985) indirectly substantiates our proposed hypothesis on the interaction between BSH activity and cholesterol. Based on these literature data, the effects on cholesterol obtained in our pig model may thus be quite promising in respect of extrapolation to the human lipid metabolism. They should nevertheless be validated in a long-term human trial, focusing on the dose-response relationship of the cholesterol-lowering effect in relation to faecal sterols, and on possible side-effects in the long run. Fermented foods containing BSH-active lactobacilli may then 'normalize' a deviating physiological condition of cholesterol metabolism, i.e. they may be preventive in the cholesterol control of people who are conscious of their unhealthy diet, but they may, on adequate dosage, also offer a valid alternative to pharmaceutical intervention in hypercholesterolaemic people.
